Fulgent Genetics, Inc. FLGT Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Fulgent Genetics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s return on equity?
- Fulgent Genetics, Inc. (FLGT) reported return on equity of -6.8% in Q1 2026.
- How has Fulgent Genetics, Inc.'s return on equity changed year-over-year?
- Fulgent Genetics, Inc.'s return on equity decreased by 87.7% year-over-year, from -3.6% to -6.8%.
- What is the long-term trend for Fulgent Genetics, Inc.'s return on equity?
- Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s return on equity has grown at a -39.4% compound annual growth rate (CAGR), from 65.7% to -5.4%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.